Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
TABERNACLE HEALTH GROUP LAUNCHES CHINESE PROPRIETARY MEDICINE, AVROCIL (TM) COLD AND FLU AID 2022-02-10 15:17
X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets 2022-02-09 22:00
Angel Yeast's Patented Probiotic S. boulardii Alleviates Common IBD Symptoms, New Research Shows 2022-02-09 21:00
Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients 2022-02-09 20:00
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors 2022-02-09 17:12
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors 2022-02-09 17:10
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers 2022-02-09 17:00
Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year 2022-02-08 22:30
WuXi Biologics Statement 2022-02-08 11:08
Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics 2022-02-08 06:00
IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research 2022-02-08 00:01
Covaris AFA-energetics™ Enables True Automated Total Nucleic Acid Extraction and Purification Workflows from FFPE Tissues 2022-02-07 23:00
Samsung Biologics receives 2022 CMO Leadership Award in all six categories 2022-02-07 20:00
Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant 2022-02-07 19:00
Laekna Launched the new domain name www.laekna.com 2022-02-07 12:47
Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037 2022-02-07 08:30
The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster 2022-02-07 08:18
Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer 2022-02-07 08:00
Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors 2022-02-06 18:30
Genesis MedTech Acquires JC Medical, Creates New Structural Heart Franchise 2022-02-05 08:00
1 181 182 183 184 185 440